The Supreme Court heard oral arguments Wednesday in a dispute over when U.S. courts are allowed to review a decision reached in arbitration — a case Justice Stephen Breyer half-jokingly called the “case of the century.”
The American Antitrust Institute is lashing out at Google Inc.'s proposed $3 billion takeover of Internet advertising firm DoubleClick Inc., arguing that publicly available information suggests that the acquisition raises serious competitive issues under several different antitrust theories.
Rambus Inc. on Wednesday argued that a court should dismiss counterclaims brought by companies it sued over memory process patents, affirming an earlier motion for summary judgment. The companies alleged that Rambus acted to monopolize the industry.
Shelby Gravel Inc. has agreed to pay $4.7 million to settle civil charges that it participated in a concrete price-fixing scandal in Indiana.
The U.S. Department of Justice has struck its first plea deals in its marine hose price-fixing and bid-rigging probe, with two Trelleborg Industrie SAS executives agreeing to speak up, pay up and go to jail.
The California Table Grape Commission violated federal antitrust laws when it squeezed out extra revenue from growers by demanding licenses and accepting royalties on three patents — covering new varieties of grapes — that it knew were invalid, according to a lawsuit filed by three companies which paid for licenses to plant and harvest the patented grapevines.
A federal judge has refused to force Johnson & Johnson subsidiary Alza Corp. to turn over 112 pages of privileged documents requested by indirect purchasers in the multidistrict litigation over bladder control drug Ditropan XL.
Arbitration's growing pains will be on display before the Supreme Court justices Wednesday, as they hear oral arguments in a unique arbitration challenge that could have a broad impact in a wide variety of disputes.
A former executive for oil-and-gas services company Willbros Group Inc. has pled guilty to bribing officials at Nigeria's state-run petroleum company in exchange for pipeline construction contracts.
A federal judge has ordered AstraZeneca and Bristol-Myers Squibb to pay Massachusetts plaintiffs in the average wholesale drug price multidistrict litigation $12.9 million and $695,594, respectively, doubling the damages requested after finding that the drug companies knowingly and willfully inflated the average wholesale prices for specific drugs.
Germany's antitrust watchdog said Monday that the European Union had found evidence that some of the country's largest utilities colluded to keep electricity prices high.
Arguing that seven remaining, non-settling defendants have no standing to object, the New York attorney general urged the court to ignore their request to hold off on granting preliminary approval to the indirect purchaser plaintiffs' settlements with Samsung Group and Winbond Electronics Corp.
The defendants in a class action over anti-competitive conduct in the insurance industry on Friday insisted that, despite arguments from several plaintiffs, not staying the case as it goes through the appeals court would cause the multidistrict litigation to “degenerate into piecemeal litigation of common issue.”
In a government action against the major drug companies over an alleged Medicare scam, the U.S. on Friday defended its right to keep secret records explaining the rationale for relying on the industry's own prices.
In a long-running antitrust battle between rival microprocessor companies, Intel Corp. has asked a federal court to force Advance Micro Devices to turn over the details of a study that claims $60 billion of Intel's profits over the past decade came from anti-competitive conduct.
Celgene Corp. is asking a New Jersey court to put the antitrust and unfair competition counterclaims Barr Laboratories Inc. lodged in response to Celgene's patent infringement complaint over the cancer drug Thalomid on the back burner, arguing that letting the counterclaims go forward now would waste the court's time.
Medco Health Solutions Inc. and Merck & Co. Inc. have accused pharmacies of distorting a recent Illinois district court decision, allegedly misinterpreting it as affirmation that agreements between buyers to depress prices paid to pharmacies constitute per se anti-competitive price-fixing.
In its long-running antitrust litigation against Mylan Laboratories over two of the generic drug maker's anti-anxiety drugs, Blue Cross Blue Shield of Massachusetts has renewed its effort to push the court to triple damages against Mylan and two drug ingredient supplier defendants, citing details from a separate case.
Madison Square Garden LP has lost the first round of its lawsuit against the National Hockey League when a district court judge declined to issue a preliminary injunction on the league's plans to collectivize all team Web sites.
Sen. Herb Kohl (D-Wis.) has introduced a bill that aims to preserve discount shopping for consumers despite a recent Supreme Court decision that discounted a century-old precedent and allowed manufacturers to set a minimum price for their products.